IDEXX Laboratories Inc. (Nasdaq: IDXX), on Wednesday posted fourth-quarter earnings and revenues that exceed market estimates and issued 2022 full-year financial guidance.
The Westbrook-based provider of veterinary diagnostics, veterinary practice software and water testing reported $1.89 in Q4 earnings per share. That’s down from $2.01 per share a year ago but well above the $1.67 consensus forecast of analysts polled by Zacks Investment Research. Read more
